An open label study to evaluate the efficacy, safety and tolerability of RWJ333369 as adjunctive therapy in subjects with partial onset seizure

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

The primary objective of this open label study is to determine the long-term safety and tolerability of RWJ-333369 as adjunctive treatment of partial onset seizures. Safety evaluation will include worsening of seizures, including rates of status epilepticus.

Critère d'inclusion

Partial Onset Epilepsy Seizures

Liens

ictrp
euctr